Train Babcock Advisors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,268
Closed -$232K 142
2014
Q4
$232K Buy
+2,268
New +$218K 0.07% 117
2014
Q3
Sell
-2,235
Closed -$201K 128
2014
Q2
$201K Sell
2,235
-87,498
-98% -$6.55M 0.07% 122
2014
Q1
$6.61M Sell
89,733
-335
-0.4% -$23.4K 2.12% 12
2013
Q4
$6.13M Buy
90,068
+7,313
+9% +$476K 2.12% 15
2013
Q3
$5.04M Sell
82,755
-9,893
-11% -$604K 1.9% 17
2013
Q2
$5.16M Buy
+92,648
New +$5.36M 1.95% 18

Train Babcock Advisors's COV Position: Q1 2015 in Review

Train Babcock Advisors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,268 shares — an estimated $232K sold.

Train Babcock Advisors first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $6.61M in Q1 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Train Babcock Advisors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Train Babcock Advisors sold 2,268 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $232K.
  • Train Babcock Advisors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Train Babcock Advisors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $6.61M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Train Babcock Advisors's 13F filing for Q1 2015, filed 23 Apr 2015.